NCT05548335

Brief Summary

This study is a prospective assessment of the accuracy of ocular ultrasound as a tool to measure the diameter of the optic nerve sheath and the eyeball transverse diameter in healthy adult patients presenting to the Emergency Department and have confirmatory imaging of the optic nerve as part of their clinical care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

2.2 years

First QC Date

July 1, 2022

Last Update Submit

August 7, 2023

Conditions

Keywords

ocular ultrasoundoptic nerve sheath diameterETD

Outcome Measures

Primary Outcomes (1)

  • The Primary objective is to determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the optic nerve sheath diameter compared to CT measurements.

    The patient will be enrolled and be involved with the study for 15-20 minutes. At this time the research procedures will be done.

    through study duration, one year is anticipated.

Secondary Outcomes (3)

  • To determine the level of intra- and inter-rater variability for ultrasound measurement of the optic nerve sheath diameter between the two transducer types.

    through study duration, one year is anticipated.

  • To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the eyeball transverse diameter compared to CT measurements.

    through study duration, one year is anticipated.

  • To determine the accuracy of the microconvex ultrasound transducer as compared to the linear ultrasound transducer for ultrasound measurement of the ONSD/ETD compared to CT measurements.

    through study duration, one year is anticipated.

Study Arms (1)

Ocular Ultrasound

OTHER

This arm includes all patients enrolled who will have an ocular ultrasound with two different probes for a total of four ultrasounds.

Procedure: Ocular Ultrasound

Interventions

1\. Patients presenting to the emergency department and have a normal head and/or ocular computed tomography scan will be considered for inclusion in this study. Study staff will discuss the study with the patient and obtain consent. At that point, operator will perform ocular ultrasound. Procedure will start with either the linear or microconvex probe. A single-use sterile gel packet will be used to apply gel to one closed eyelid. The probe will be placed with minimal pressure on the eye. A transverse measurement of the ONSD will be taken. In this same view the maximal transverse diameter of the eyeball will also be measured. Images of the eye with ONSD and ETD measurements will be captured. Repeat until three measurements have been obtained resulting in an average ONSD and ETD for that eye. Repeat for other eye. Switch probe and repeat on both eyes.

Ocular Ultrasound

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older, and;
  • Present to Cleveland Clinic Akron General's ED (Main)
  • Have CT head and/or ocular ordered as a part of clinical care that is read as normal or no acute disease (confirmatory imaging), and;
  • Agree to and provide written consent for participation.

You may not qualify if:

  • Acute ocular pathology
  • Abnormal brain and/or ocular CT
  • History of increased intracranial pressure or optic nerve disease
  • Not medically stable
  • Pregnant or incarcerated
  • Unable to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Akron General

Akron, Ohio, 44307, United States

RECRUITING

Study Officials

  • Joshua Jacquet, MD

    Cleveland Clinic Akron General

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joshua Jacquet, MD

CONTACT

Jessica Krizo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking. All subjects have same intervention.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: There are no groups. All subjects will have the same inclusion criteria and will have the same intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

July 1, 2022

First Posted

September 21, 2022

Study Start

October 1, 2022

Primary Completion

December 30, 2024

Study Completion

December 31, 2024

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations